- Home
- HFWA vs MDXG Comparison
HFWA vs MDXG Comparison
Compare HFWA & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HFWA
- MDXG
- Stock Information
- Founded
- HFWA 1927
- MDXG 2006
- Country
- HFWA United States
- MDXG United States
- Employees
- HFWA N/A
- MDXG N/A
- Industry
- HFWA Banks
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- HFWA Finance
- MDXG Health Care
- Exchange
- HFWA Nasdaq
- MDXG Nasdaq
- Market Cap
- HFWA 843.8M
- MDXG 999.9M
- IPO Year
- HFWA N/A
- MDXG N/A
- Fundamental
- Price
- HFWA $22.57
- MDXG $5.81
- Analyst Decision
- HFWA Hold
- MDXG Strong Buy
- Analyst Count
- HFWA 3
- MDXG 2
- Target Price
- HFWA $27.67
- MDXG $12.50
- AVG Volume (30 Days)
- HFWA 170.7K
- MDXG 505.5K
- Earning Date
- HFWA 07-24-2025
- MDXG 07-30-2025
- Dividend Yield
- HFWA 4.25%
- MDXG N/A
- EPS Growth
- HFWA 11.50
- MDXG N/A
- EPS
- HFWA 1.48
- MDXG 0.27
- Revenue
- HFWA $220,859,000.00
- MDXG $352,375,000.00
- Revenue This Year
- HFWA $23.49
- MDXG $9.55
- Revenue Next Year
- HFWA $7.68
- MDXG $11.43
- P/E Ratio
- HFWA $15.22
- MDXG $21.73
- Revenue Growth
- HFWA 0.16
- MDXG 5.34
- 52 Week Low
- HFWA $16.69
- MDXG $5.47
- 52 Week High
- HFWA $27.58
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- HFWA 42.55
- MDXG 30.41
- Support Level
- HFWA $22.27
- MDXG $5.80
- Resistance Level
- HFWA $22.92
- MDXG $6.03
- Average True Range (ATR)
- HFWA 0.52
- MDXG 0.19
- MACD
- HFWA -0.11
- MDXG -0.05
- Stochastic Oscillator
- HFWA 17.54
- MDXG 2.47
About HFWA Heritage Financial Corporation
Heritage Financial Corp is a bank holding company. The company through its subsidiary provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as noninterest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.